As the development of targeted radiopharmaceuticals and antibody-drug conjugates (ADCs) accelerates, Alfa Cytology has enhanced its radiopharmaceutical development service portfolio by integrating custom radiolabeling with physicochemical characterization services. The company now provides comprehensive research support for biotechnology and pharmaceutical companies, as well as scientific research institutions.
Radiopharmaceuticals have become a critical area in precision medicine, with radiolabeling technologies increasingly used for pharmacokinetic studies, biodistribution analysis, and molecular imaging. The rapid growth of ADCs, peptide therapeutics, and targeted small molecules has further driven demand for advanced radiopharmaceutical capabilities. However, successful radiolabeling is only one step; key attributes such as radiochemical purity, stability, lipophilicity, and target-binding capability require systematic evaluation. Alfa Cytology addresses this need by offering both radiolabeling and characterization services in an integrated approach.
The company's custom radiolabeling for ADCs and targeted radiopharmaceuticals supports antibodies, ADCs, peptide therapeutics, small molecules, and other compounds, using a variety of radionuclides for diagnostic and therapeutic applications. These services are applicable to pharmacokinetic studies, biodistribution analysis, molecular imaging, and radiopharmaceutical development.
Additionally, Alfa Cytology offers radiopharmaceutical physicochemical characterization CRO services that analyze radiochemical purity, stability, lipophilicity (LogP/LogD), and immunoreactivity. These systematic studies help research teams evaluate candidate properties and generate reliable data for subsequent research.
"The demand for high-quality radiolabeling and physicochemical characterization data continues to grow as radiopharmaceutical development advances," said a spokesperson for Alfa Cytology. "By integrating our technical capabilities, we aim to provide customers with more efficient research support and help advance the development of innovative radiopharmaceuticals and targeted therapies."
Alfa Cytology is a professional service provider focused on biomedical research and development support, offering services in radiopharmaceutical development, drug discovery, preclinical research, and related biotechnology services.
